Loading…

Sample size and power calculations in repeated measurement analysis

Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference betwee...

Full description

Saved in:
Bibliographic Details
Published in:Computer methods and programs in biomedicine 2001-02, Vol.64 (2), p.121-124
Main Authors: Ahn, Chul, Overall, John E, Tonidandel, Scott
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c451t-79498212fdc212703e3cae7ae95a932e0ba63866dc710b67ec9331b8be1e802d3
cites cdi_FETCH-LOGICAL-c451t-79498212fdc212703e3cae7ae95a932e0ba63866dc710b67ec9331b8be1e802d3
container_end_page 124
container_issue 2
container_start_page 121
container_title Computer methods and programs in biomedicine
container_volume 64
creator Ahn, Chul
Overall, John E
Tonidandel, Scott
description Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference between patterns or magnitudes of change from baseline. A simple two-stage approach to the analysis of such data involves calculation of an index or coefficient of change in stage 1 and testing the significance of difference between group means on the derived measure of change in stage 2. This article has the aim of introducing formulas and a computer program for sample size and/or power calculations for such two-stage analyses involving each of three definitions of change, with or without baseline scores entered as a covariate, in the presence of homogeneous or heterogeneous (autoregressive) patterns of correlation among the repeated measurements. Empirical adjustments of sample size for the projected dropout rates are also provided in the computer program.
doi_str_mv 10.1016/S0169-2607(00)00095-X
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70583439</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S016926070000095X</els_id><sourcerecordid>525577</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-79498212fdc212703e3cae7ae95a932e0ba63866dc710b67ec9331b8be1e802d3</originalsourceid><addsrcrecordid>eNqF0U1r3DAQBmBRGpptmp_QYiiE5uB2RrIk61TK0qSFQA5pIDchy7Og4q9KdkPy66PNLslxL6PLM5J4X8Y-InxFQPXtJg9TcgX6C8A5ABhZ3r1hK6w1L7VU8i1bvZBj9j6lvxlxKdU7doyIQqOpVmx94_qpoyKFRyrc0BbTeE-x8K7zS-fmMA6pCEMRaSI3U1v05NISqadhztx1DymkD-xo47pEp_vzhN1e_Pyz_lVeXV_-Xv-4Kn0lcS61qUzNkW9an6cGQcI70o6MdEZwgsYpUSvVeo3QKE3eCIFN3RBSDbwVJ-xsd-8Ux38Lpdn2IXnqOjfQuCSrQdaiEuYg5FgpBMUPQqxVxSVAhnIHfRxTirSxUwy9iw8WwW77sM992G3YFsA-92Hv8t6n_QNL01P7urUvIIPPe-BSDn0T3eBDenG1UQq36vtOUY73f6Bokw80eGpDJD_bdgwHPvIEiCSmAw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>18642500</pqid></control><display><type>article</type><title>Sample size and power calculations in repeated measurement analysis</title><source>ScienceDirect Journals</source><creator>Ahn, Chul ; Overall, John E ; Tonidandel, Scott</creator><creatorcontrib>Ahn, Chul ; Overall, John E ; Tonidandel, Scott</creatorcontrib><description>Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference between patterns or magnitudes of change from baseline. A simple two-stage approach to the analysis of such data involves calculation of an index or coefficient of change in stage 1 and testing the significance of difference between group means on the derived measure of change in stage 2. This article has the aim of introducing formulas and a computer program for sample size and/or power calculations for such two-stage analyses involving each of three definitions of change, with or without baseline scores entered as a covariate, in the presence of homogeneous or heterogeneous (autoregressive) patterns of correlation among the repeated measurements. Empirical adjustments of sample size for the projected dropout rates are also provided in the computer program.</description><identifier>ISSN: 0169-2607</identifier><identifier>EISSN: 1872-7565</identifier><identifier>DOI: 10.1016/S0169-2607(00)00095-X</identifier><identifier>PMID: 11137194</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Biological and medical sciences ; Computer simulation ; Computerized, statistical medical data processing and models in biomedicine ; Controlled Clinical Trials as Topic - statistics &amp; numerical data ; Dropouts ; Humans ; Medical sciences ; Medical statistics ; Numerical analysis ; Power calculation ; Repeated measures ; Sample Size ; Sample size estimate ; Schizophrenia - drug therapy ; Software</subject><ispartof>Computer methods and programs in biomedicine, 2001-02, Vol.64 (2), p.121-124</ispartof><rights>2001 Elsevier Science Ireland Ltd</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-79498212fdc212703e3cae7ae95a932e0ba63866dc710b67ec9331b8be1e802d3</citedby><cites>FETCH-LOGICAL-c451t-79498212fdc212703e3cae7ae95a932e0ba63866dc710b67ec9331b8be1e802d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=896614$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11137194$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ahn, Chul</creatorcontrib><creatorcontrib>Overall, John E</creatorcontrib><creatorcontrib>Tonidandel, Scott</creatorcontrib><title>Sample size and power calculations in repeated measurement analysis</title><title>Computer methods and programs in biomedicine</title><addtitle>Comput Methods Programs Biomed</addtitle><description>Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference between patterns or magnitudes of change from baseline. A simple two-stage approach to the analysis of such data involves calculation of an index or coefficient of change in stage 1 and testing the significance of difference between group means on the derived measure of change in stage 2. This article has the aim of introducing formulas and a computer program for sample size and/or power calculations for such two-stage analyses involving each of three definitions of change, with or without baseline scores entered as a covariate, in the presence of homogeneous or heterogeneous (autoregressive) patterns of correlation among the repeated measurements. Empirical adjustments of sample size for the projected dropout rates are also provided in the computer program.</description><subject>Biological and medical sciences</subject><subject>Computer simulation</subject><subject>Computerized, statistical medical data processing and models in biomedicine</subject><subject>Controlled Clinical Trials as Topic - statistics &amp; numerical data</subject><subject>Dropouts</subject><subject>Humans</subject><subject>Medical sciences</subject><subject>Medical statistics</subject><subject>Numerical analysis</subject><subject>Power calculation</subject><subject>Repeated measures</subject><subject>Sample Size</subject><subject>Sample size estimate</subject><subject>Schizophrenia - drug therapy</subject><subject>Software</subject><issn>0169-2607</issn><issn>1872-7565</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><recordid>eNqF0U1r3DAQBmBRGpptmp_QYiiE5uB2RrIk61TK0qSFQA5pIDchy7Og4q9KdkPy66PNLslxL6PLM5J4X8Y-InxFQPXtJg9TcgX6C8A5ABhZ3r1hK6w1L7VU8i1bvZBj9j6lvxlxKdU7doyIQqOpVmx94_qpoyKFRyrc0BbTeE-x8K7zS-fmMA6pCEMRaSI3U1v05NISqadhztx1DymkD-xo47pEp_vzhN1e_Pyz_lVeXV_-Xv-4Kn0lcS61qUzNkW9an6cGQcI70o6MdEZwgsYpUSvVeo3QKE3eCIFN3RBSDbwVJ-xsd-8Ux38Lpdn2IXnqOjfQuCSrQdaiEuYg5FgpBMUPQqxVxSVAhnIHfRxTirSxUwy9iw8WwW77sM992G3YFsA-92Hv8t6n_QNL01P7urUvIIPPe-BSDn0T3eBDenG1UQq36vtOUY73f6Bokw80eGpDJD_bdgwHPvIEiCSmAw</recordid><startdate>20010201</startdate><enddate>20010201</enddate><creator>Ahn, Chul</creator><creator>Overall, John E</creator><creator>Tonidandel, Scott</creator><general>Elsevier Ireland Ltd</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20010201</creationdate><title>Sample size and power calculations in repeated measurement analysis</title><author>Ahn, Chul ; Overall, John E ; Tonidandel, Scott</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-79498212fdc212703e3cae7ae95a932e0ba63866dc710b67ec9331b8be1e802d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Biological and medical sciences</topic><topic>Computer simulation</topic><topic>Computerized, statistical medical data processing and models in biomedicine</topic><topic>Controlled Clinical Trials as Topic - statistics &amp; numerical data</topic><topic>Dropouts</topic><topic>Humans</topic><topic>Medical sciences</topic><topic>Medical statistics</topic><topic>Numerical analysis</topic><topic>Power calculation</topic><topic>Repeated measures</topic><topic>Sample Size</topic><topic>Sample size estimate</topic><topic>Schizophrenia - drug therapy</topic><topic>Software</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ahn, Chul</creatorcontrib><creatorcontrib>Overall, John E</creatorcontrib><creatorcontrib>Tonidandel, Scott</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Computer methods and programs in biomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ahn, Chul</au><au>Overall, John E</au><au>Tonidandel, Scott</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sample size and power calculations in repeated measurement analysis</atitle><jtitle>Computer methods and programs in biomedicine</jtitle><addtitle>Comput Methods Programs Biomed</addtitle><date>2001-02-01</date><risdate>2001</risdate><volume>64</volume><issue>2</issue><spage>121</spage><epage>124</epage><pages>121-124</pages><issn>0169-2607</issn><eissn>1872-7565</eissn><abstract>Controlled clinical trials in neuropsychopharmacology, as in numerous other clinical research domains, tend to employ a conventional parallel-groups design with repeated measurements. The hypothesis of primary interest in the relatively short-term, double-blind trials, concerns the difference between patterns or magnitudes of change from baseline. A simple two-stage approach to the analysis of such data involves calculation of an index or coefficient of change in stage 1 and testing the significance of difference between group means on the derived measure of change in stage 2. This article has the aim of introducing formulas and a computer program for sample size and/or power calculations for such two-stage analyses involving each of three definitions of change, with or without baseline scores entered as a covariate, in the presence of homogeneous or heterogeneous (autoregressive) patterns of correlation among the repeated measurements. Empirical adjustments of sample size for the projected dropout rates are also provided in the computer program.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>11137194</pmid><doi>10.1016/S0169-2607(00)00095-X</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0169-2607
ispartof Computer methods and programs in biomedicine, 2001-02, Vol.64 (2), p.121-124
issn 0169-2607
1872-7565
language eng
recordid cdi_proquest_miscellaneous_70583439
source ScienceDirect Journals
subjects Biological and medical sciences
Computer simulation
Computerized, statistical medical data processing and models in biomedicine
Controlled Clinical Trials as Topic - statistics & numerical data
Dropouts
Humans
Medical sciences
Medical statistics
Numerical analysis
Power calculation
Repeated measures
Sample Size
Sample size estimate
Schizophrenia - drug therapy
Software
title Sample size and power calculations in repeated measurement analysis
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T20%3A54%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sample%20size%20and%20power%20calculations%20in%20repeated%20measurement%20analysis&rft.jtitle=Computer%20methods%20and%20programs%20in%20biomedicine&rft.au=Ahn,%20Chul&rft.date=2001-02-01&rft.volume=64&rft.issue=2&rft.spage=121&rft.epage=124&rft.pages=121-124&rft.issn=0169-2607&rft.eissn=1872-7565&rft_id=info:doi/10.1016/S0169-2607(00)00095-X&rft_dat=%3Cproquest_cross%3E525577%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-79498212fdc212703e3cae7ae95a932e0ba63866dc710b67ec9331b8be1e802d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=18642500&rft_id=info:pmid/11137194&rfr_iscdi=true